These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8965249)

  • 1. Cytochrome-P450 induction and antineoplastic action of fotemustine in mice.
    Isa M; Cumps J; Poupaert JH; Atassi G
    J Pharm Belg; 1996; 51(4):192-4. PubMed ID: 8965249
    [No Abstract]   [Full Text] [Related]  

  • 2. Nitrosourea derivatives of tertiary phosphine oxides.
    Gugova R; Varbanov S; Raikov Z; Demirov G; Todorov D; Ilarionova
    Pharmazie; 1991 Aug; 46(8):603. PubMed ID: 1798718
    [No Abstract]   [Full Text] [Related]  

  • 3. Activity of fotemustine in medulloblastoma and malignant glioma xenografts in relation to O6-alkylguanine-DNA alkyltransferase and alkylpurine-DNA N-glycosylase activity.
    Vassal G; Boland I; Terrier-Lacombe MJ; Watson AJ; Margison GP; Vénuat AM; Morizet J; Parker F; Lacroix C; Lellouch-Tubiana A; Pierre-Kahn A; Poullain MG; Gouyette A
    Clin Cancer Res; 1998 Feb; 4(2):463-8. PubMed ID: 9516937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [DNA damage induced by fotemustine in cultured HL60 cells].
    Shou J; Feng XW
    Zhongguo Yao Li Xue Bao; 1996 Sep; 17(5):474-7. PubMed ID: 9863179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of dipin on inductive synthesis of cytochrome P450 in the endoplasmic reticulum of rat liver cells].
    Klimenko VV; Nemirovskiĭ LE
    Biull Eksp Biol Med; 1973 May; 75(5):38-40. PubMed ID: 4778682
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of the new nitrosourea derivative, fotemustine, on the glutathione reductase activity in rat tissues in vivo and in isolated rat hepatocytes.
    Boutin JA; Norbeck K; Moldeus P; Genton A; Paraire M; Bizzari JP; Lavielle G; Cudennec CA
    Eur J Cancer Clin Oncol; 1989 Sep; 25(9):1311-6. PubMed ID: 2806354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effects of fotemustine and busulfan against a human neuroblastoma xenograft.
    Ikeda H; Tsuchida Y; Wu J; Suzuki N; Kuroiwa M; Choi SH; Morikawa A
    Oncol Rep; 2000; 7(6):1265-8. PubMed ID: 11032927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interspecies comparison of pharmacokinetic parameters of fotemustine (nitrosourea S 10036): mice, rats, monkeys, dogs and man].
    Lucas C; Ings B; Gray AJ; Deloffre P; Lokiec F; Campbell B; Beerblock K
    Bull Cancer; 1989; 76(8):863-5. PubMed ID: 2515897
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal hemodynamic and tubular effects of S 10036 (fotemustine) in man.
    Deray G; Khayat D; Bizzari JP; Jacquillat C
    Clin Nephrol; 1989 Sep; 32(3):150. PubMed ID: 2791369
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mechanism of the transport of novel nitrosoalkylurea derivative, nitrulline, into tumor and normal cells].
    Shulepova TS; Belousova AK
    Biull Eksp Biol Med; 1996 Dec; 122(12):648-50. PubMed ID: 9280464
    [No Abstract]   [Full Text] [Related]  

  • 11. Phosphorohydrazines of 4-oxo-4H-1-benzopyran and 1-benzopyran-2,4-dione exhibit antitumor activity against L1210 leukemia.
    Nawrot-Modranka J; Ochocki J; Graczyk J
    Pharmazie; 2004 Sep; 59(9):731-2. PubMed ID: 15497762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotoxic, cytostatic, antineoplastic and apoptotic effects of newly synthesized antitumour steroidal esters.
    Karapidaki I; Bakopoulou A; Papageorgiou A; Iakovidou Z; Mioglou E; Nikolaropoulos S; Mourelatos D; Lialiaris T
    Mutat Res; 2009 Apr; 675(1-2):51-9. PubMed ID: 19386248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of new nitrosoureas esters with modified steroidal nucleus for cytogenetic and antineoplastic activity.
    Hussein A; Mioglou-Kalouptsi E; Papageorgiou A; Karapidaki I; Iakovidou-Kritsi Z; Lialiaris T; Xrysogelou E; Camoutsis C; Mourelatos D
    In Vivo; 2007; 21(2):389-95. PubMed ID: 17436593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of Fotemustine analogues on human melanoma cell lines.
    Winum JY; Bouissière JL; Passagne I; Evrard A; Montero V; Cuq P; Montero JL
    Eur J Med Chem; 2003 Mar; 38(3):319-24. PubMed ID: 12667699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of cytochrome P-450 induction as 1 of the new principles of therapy in organophosphate insecticide poisonings].
    Kagan IuS; Kokshareva NV; Ovsiannikova LM; Samusenko II
    Vestn Akad Med Nauk SSSR; 1980; (8):55-8. PubMed ID: 7415524
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemosensitivity of conjunctival melanoma cell lines to chemotherapeutic agents.
    Westekemper H; Freistuehler M; Anastassiou G; Nareyeck G; Zeschnigk M; Bornfeld N; Steuhl KP; Scheulen ME; Hilger RA
    Int J Clin Pharmacol Ther; 2011 Jan; 49(1):78-80. PubMed ID: 21176737
    [No Abstract]   [Full Text] [Related]  

  • 17. Sensitivity and resistance in human metastatic melanoma to the new chloroethylnitrosourea anti-tumor drug Fotemustine.
    Schallreuter KU; Wood JM
    Biochim Biophys Acta; 1991 Jun; 1096(4):277-83. PubMed ID: 2065101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
    Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P
    Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Action mechanism of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in leukemic cells].
    Nakamura T; Hashimoto E; Sasada M; Tsutani H; Kagawa D; Ueda T; Uchida M; Domae N; Ando S; Uchino H
    Nihon Ketsueki Gakkai Zasshi; 1985 May; 48(3):734-41. PubMed ID: 3862320
    [No Abstract]   [Full Text] [Related]  

  • 20. Focus on Fotemustine.
    De Rossi A; Rossi L; Laudisi A; Sini V; Toppo L; Marchesi F; Tortorelli G; Leti M; Turriziani M; Aquino A; Bonmassar E; De Vecchis L; Torino F
    J Exp Clin Cancer Res; 2006 Dec; 25(4):461-8. PubMed ID: 17310834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.